The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Brivaracetam and Levetiracetam Suppress Astroglial L-Glutamate Release through Hemichannel via Inhibition of Synaptic Vesicle Protein
Open accessAbstract
To explore the pathophysiological mechanisms of antiseizure and adverse behavioural/psychiatric effects of brivaracetam and levetiracetam, in the present study, we determined the effects of brivaracetam and levetiracetam on astroglial L-glutamate release induced by artificial high-frequency oscillation (HFO) bursts using ultra-high-performance liquid chromatography. Additionally, the effects of brivaracetam and levetiracetam on protein expressions of connexin43 (Cx43) and synaptic vesicle protein 2A (SV2A) in the plasma membrane of primary cultured rat astrocytes were determined using a capillary immunoblotting system. Acutely artificial fast-ripple HFO (500 Hz) burst stimulation use-dependently increased L-glutamate release through Cx43-containing hemichannels without affecting the expression of Cx43 or SV2A in the plasma membrane, whereas acute physiological ripple HFO (200 Hz) stimulation did not affect astroglial L-glutamate release or expression of Cx43 or SV2A. Contrarily, subchronic ripple HFO and acute pathological fast-ripple HFO (500 Hz) stimulations use-dependently increased L-glutamate release through Cx43-containing hemichannels and Cx43 expression in the plasma membrane. Subchronic fast-ripple HFO-evoked stimulation produced ectopic expression of SV2A in the plasma membrane, but subchronic ripple HFO stimulation did not generate ectopic SV2A. Subchronic administration of brivaracetam and levetiracetam concentration-dependently suppressed fast-ripple HFO-induced astroglial L-glutamate release and expression of Cx43 and SV2A in the plasma membrane. In contrast, subchronic ripple HFO-evoked stimulation induced astroglial L-glutamate release, and Cx43 expression in the plasma membrane was inhibited by subchronic levetiracetam administration, but was not affected by brivaracetam. These results suggest that brivaracetam and levetiracetam inhibit epileptogenic fast-ripple HFO-induced activated astroglial transmission associated with hemichannels. In contrast, the inhibitory effect of therapeutic-relevant concentrations of levetiracetam on physiological ripple HFO-induced astroglial responses probably contributes to the adverse behavioural/psychiatric effects of levetiracetam.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Both agents reduce pathologic astroglial glutamate release, supporting glutamatergic homeostasis during periods of heightened network demand [203,204].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [203]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017
Hiemke, C., Bergemann, N., Clement, H., Conca, A., Deckert, J., Domschke, K., Eckermann, G., Egberts, K., Gerlach, M., Greiner, C., et al. (2018) · Pharmacopsychiatry · doi:10.1055/s-0043-116492 · Cited by 1,446 · cited 1×
“It has been considered that the candidate therapeutic-relevant concentrations of brivaracetam and levetiracetam range from 2 to 6 μM and from 70 to 270 μM, respectively [35,36].”
The cognitive impact of antiepileptic drugs
Eddy, C. M., Rickards, H. E., & Cavanna, A. E. (2011) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285611417920 · Cited by 404
Brain neural patterns and the memory function of sleep
Girardeau, G., & Lopes-dos-Santos, V. (2021) · Science · doi:10.1126/science.abi8370 · Cited by 293 · cited 2×
“It is speculated that sleep spindle/ripple HFO bursts provide the formation and/or maintenance of a part of cognitive function [29].”
BackgroundEpilepsy, Antiepileptic Drugs, and Aggression: An Evidence-Based Review
Brodie, M. J., Besag, F., Ettinger, A. B., Mula, M., Gobbi, G., Comai, S., Aldenkamp, A. P., & Steinhoff, B. J. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.012021 · Cited by 288 · cited 1×
“Considering the impacts on quality of life, adverse behavioural or psychiatric events induced by antiseizure drugs play important roles in the decisions regarding antiepileptic medication [6,11].”
BackgroundHippocampal sharp-wave ripples linked to visual episodic recollection in humans
Norman, Y., Yeagle, E. M., Khuvis, S., Harel, M., Mehta, A. D., & Malach, R. (2019) · Science · doi:10.1126/science.aax1030 · Cited by 270 · cited 1×
“Recent psychophysiological studies have accumulated findings that ripple HFO and sleep spindle play important roles in the generation of several subdomains of cognition, such as perceptual/sensory integration, reasoning ability, and memory consolidation [29,61,62].”
BackgroundAdverse antiepileptic drug effects: Toward a clinically and neurobiologically relevant taxonomy
Perucca, P., Carter, J., Vahle, V., & Gilliam, F. G. (2009) · Neurology · doi:10.1212/01.wnl.0000345667.45642.61 · Cited by 237 · cited 1×
“Considering the impacts on quality of life, adverse behavioural or psychiatric events induced by antiseizure drugs play important roles in the decisions regarding antiepileptic medication [6,11].”
BackgroundRibeiro-Rodrigues, T. M., Martins-Marques, T., Morel, S., Kwak, B. R., & Girão, H. (2017) · Journal of Cell Science · doi:10.1242/jcs.200667 · Cited by 203 · cited 1×
“The six assembling connexins (connexon) in the plasma membrane connect with the other connexon in the plasma membrane in various neighbouring cells, neurons, astrocytes, oligodendrocytes, and microglia, forming a gap junction [20].”
BackgroundCramer, J. (2003) · Epilepsy & Behavior · doi:10.1016/s1525-5050(03)00005-2 · Cited by 190
Mutch, S. A., Kensel-Hammes, P., Gadd, J. C., Fujimoto, B. S., Allen, R. W., Schiro, P. G., Lorenz, R. M., Kuyper, C. L., Kuo, J. S., Bajjalieh, S. M., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3805-10.2011 · Cited by 185 · cited 1×
“SV2A is ubiquitously expressed in various structures in the central nervous system but selectively expressed in the synaptic vesicle membrane, with five copies in each vesicle [12,13].”
BackgroundKlitgaard, H., Matagne, A., Nicolas, J., Gillard, M., Lamberty, Y., De Ryck, M., Kaminski, R. M., Leclercq, K., Niespodziany, I., Wolff, C., et al. (2016) · Epilepsia · doi:10.1111/epi.13340 · Cited by 168
Cited by
Therapeutic Potential and Limitation of Serotonin Type 7 Receptor Modulation
Fukuyama, K., Motomura, E., & Okada, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032070 · Cited by 36
Self-citationOkada, M., Fukuyama, K., & Motomura, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169103 · Cited by 17
“A recent study reported that ripple burst could be involved in ictogenesis in the networks that have acquired vulnerability to epileptogenesis [49,51].”
BackgroundSelf-citationPresynaptic antiseizure medications-basic mechanisms and clues for their rational combinations
Czapińska-Ciepiela, E. K., Łuszczki, J., Czapiński, P., Czuczwar, S. J., & Lasoń, W. (2024) · Pharmacological Reports · doi:10.1007/s43440-024-00603-7 · Cited by 13
Anti-seizure Medications: Challenges and Opportunities
Tandon, N., Radosavljević, M., Vučević, D. B., Radenković, M., Jančić, J., & Samardžić, J. (2024) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273275793231030060833 · Cited by 15
Ismail, F. S., Faustmann, P. M., Kümmel, M.-L., Förster, E., Faustmann, T. J., & Corvace, F. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.995861 · Cited by 12
“The antiseizure effect of BRV was discussed to be mediated by suppression of SV2A and subsequent inhibition of turnover prolongation of Cx43 hemichannels in the plasma membrane (Fukuyama and Okada, 2022).”
Background
Metadata
- Authors
- Fukuyama, K., & Okada, M.
- Affiliations
- Mie University (JP)
- Corresponding author
- Okada, Motohiro
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-04-19
- Volume
- 23
- Issue
- 9
- Pages
- 4473
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC9101419
- OpenAlex
- W4280525086
- Cited by
- 22
- References
- 72
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 5 · 2023: 3 · 2022: 4
- FWCI
- 2.77
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Japan Epilepsy Research Foundation (JERF TENKAN 21008)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Connexins and lens biology
- Keywords
- brivaracetam, levetiracetam, connexin 43, hemichannels, SV2A, epileptogenic activity, antiepileptic drugs, astrocytes
- MeSH terms
- Levetiracetam, Animals, Anticonvulsants, Astrocytes, Pyrrolidinones, Synaptic Vesicles, Connexin 43, Glutamic Acid, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Brivaracetam and Levetiracetam Suppress Astroglial L-Glutamate Release through Hemichannel via Inhibition of Synaptic Vesicle Protein. https://app.cochat.ai/papers/10.3390/ijms23094473
- The paper
- Fukuyama, K., & Okada, M. (2022). Brivaracetam and Levetiracetam Suppress Astroglial L-Glutamate Release through Hemichannel via Inhibition of Synaptic Vesicle Protein. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms23094473
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.